Ionis Pharmaceuticals Inc financial data

Symbol
IONS on Nasdaq
Industry
Pharmaceutical Preparations
Location
2855 Gazelle Court, Carlsbad, California
State of incorporation
California
Fiscal year end
December 31
Former names
ISIS PHARMACEUTICALS INC (to 12/18/2015)
Latest financial report
10-Q - Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 699 % -13.7%
Quick Ratio 7.48 % -0.8%
Debt-to-equity 717 % +104%
Return On Equity -90.8 % -8475%
Return On Assets -13.2 % -3.37%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 146 M shares +2.01%
Common Stock, Shares, Outstanding 146 M shares +1.97%
Entity Public Float 4.24 B USD +11.5%
Common Stock, Value, Issued 146 K USD +2.1%
Weighted Average Number of Shares Outstanding, Basic 146 M shares +1.96%
Weighted Average Number of Shares Outstanding, Diluted 146 M shares +1.96%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 325 M USD +114%
Revenue from Contract with Customer, Excluding Assessed Tax 777 M USD +34.8%
Costs and Expenses 1.17 B USD +11.8%
Operating Income (Loss) -389 M USD +16.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -364 M USD -18.5%
Income Tax Expense (Benefit) 21 M USD -4.57%
Net Income (Loss) Attributable to Parent -385 M USD -17%
Earnings Per Share, Basic -2.67 USD/shares -15.6%
Earnings Per Share, Diluted -2.67 USD/shares -15.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 349 M USD +12.9%
Inventory, Net 30.3 M USD +36.3%
Other Assets, Current 174 M USD +8.98%
Assets, Current 2.42 B USD -4.99%
Property, Plant and Equipment, Net 72.8 M USD -14.5%
Operating Lease, Right-of-Use Asset 169 M USD -5.42%
Other Assets, Noncurrent 106 M USD +35.4%
Assets 2.76 B USD -4.2%
Accounts Payable, Current 13.1 M USD +24.6%
Employee-related Liabilities, Current 21.5 M USD +18.6%
Accrued Liabilities, Current 106 M USD -5.9%
Contract with Customer, Liability, Current 130 M USD +41.2%
Liabilities, Current 328 M USD +26.4%
Contract with Customer, Liability, Noncurrent 215 M USD -21.2%
Operating Lease, Liability, Noncurrent 169 M USD -4.7%
Other Liabilities, Noncurrent 41.8 M USD +458%
Liabilities 2.47 B USD +2.87%
Accumulated Other Comprehensive Income (Loss), Net of Tax -35 M USD +28.6%
Retained Earnings (Accumulated Deficit) -1.94 B USD -24.8%
Stockholders' Equity Attributable to Parent 297 M USD -39.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 315 M USD -46.9%
Liabilities and Equity 2.76 B USD -4.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -150 M USD -11.9%
Net Cash Provided by (Used in) Financing Activities 23.6 M USD -95.2%
Net Cash Provided by (Used in) Investing Activities 76.1 M USD
Common Stock, Shares Authorized 300 M shares 0%
Common Stock, Shares, Issued 146 M shares +1.97%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -50.4 M USD -255%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 349 M USD +12.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 95 K USD +6.74%
Deferred Tax Assets, Valuation Allowance 978 M USD +20.9%
Deferred Tax Assets, Gross 1.03 B USD +19.5%
Operating Lease, Liability 179 M USD -3.86%
Depreciation 2.55 M USD -2.19%
Payments to Acquire Property, Plant, and Equipment 4.49 M USD -57.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -371 M USD -12.6%
Lessee, Operating Lease, Liability, to be Paid 280 M USD -6.7%
Operating Lease, Liability, Current 8.09 M USD +12.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.6 M USD +1.25%
Lessee, Operating Lease, Liability, to be Paid, Year One 20.4 M USD +1.63%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 101 M USD -11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20.8 M USD +0.68%
Deferred Tax Assets, Operating Loss Carryforwards 78 M USD -11.2%
Unrecognized Tax Benefits 43.3 M USD -23.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 20.8 M USD +0.09%
Amortization of Intangible Assets 639 K USD +5.27%
Share-based Payment Arrangement, Expense 110 M USD +9.14%
Interest Expense 15.2 M USD +99.8%